Safety and Efficacy of Aneurysms Treated With Endovascular Devices

In this project the investigators study the safety and efficacy of the recent endovascular devices used in treatment of brain aneurysms.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Brain Aneurysm Aneurysm Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Hemorrhage Intracranial Aneurysm Intracranial Arterial Diseases Intracranial Hemorrhages Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Stroke Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Kings College Hospital, London

London, United Kingdom

Location status: Recruiting

Location contact

Thomas Booth

CONTACT

[email protected]

02032994828

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients undergoing endovascular aneurysm treatment.

Exclusion criteria

All endovascular patients NOT undergoing aneurysm treatment e.g. stents used for stroke treatment; devices and materials used for dAVF, AVM treatments.
Insufficient background data available e.g., to determine size of aneurysm and device.

Treatment and study plan

Endovascular treatment of aneurysms

Device

Aneurysm can be treated by endovascular devices using catheters, Treatment modalities can include coils, stents, flow diverters as well as intrasaccular devices

Primary outcomes

Evaluate predictive factors of aneurysm recurrence after endovascular device embolization (efficacy).

Time frame: Done at short-term (30 days) post procedural and long term (up to 5 years) post procedural

Change of aneurysm from Raymond Roy (RR) classification I into RR II or RR III and correlating this with factors such as smoking.

Sponsors and collaborators

Lead sponsor

King's College London

Other

Registry information

Acronym: SEATED

Important dates

Study start: 2025
Primary completion: 2035
Study completion: 2035
First posted: Sep 16, 2025
Registry last updated: Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed